I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Marasca, C.
145
results:
Search for persons
X
Format
Online (145)
Mediatypes
Articles (Online) (40)
OpenAccess-fulltext (105)
Languages
english (134)
more...
portuguese (5)
spanish (1)
latin (2)
less...
Sorted by: Year
Sorted by: Relevance
?
1
Secukinumab in Hidradenitis Suppurativa Patients Who Failed..:
Martora F
;
Marasca C
;
Cacciapuoti S
...
https://www.dovepress.com/secukinumab-in-hidradenitis-suppurativa-patients-who-failed-adalimumab-peer-reviewed-fulltext-article-CCID. , 2024
Link:
https://doaj.org/article..
?
2
Long‐term efficacy and safety of zanubrutinib (ZANU) in rel..:
Trotman, J.
;
Tedeschi, A.
;
Hu, B.
...
Hematological Oncology. 41 (2023) S2 - p. 390-392 , 2023
Link:
https://doi.org/10.1002/..
?
3
Adalimumab, Ustekinumab, and Secukinumab in the Management ..:
Martora F
;
Megna M
;
Battista T
...
https://www.dovepress.com/adalimumab-ustekinumab-and-secukinumab-in-the-management-of-hidradenit-peer-reviewed-fulltext-article-CCID. , 2023
Link:
https://doaj.org/article..
?
4
Friedman tongue position and the anthropometric parameters ..:
Luzzi V
;
Altieri F
;
Guaragna M
...
info:eu-repo/semantics/altIdentifier/pmid/36833949. , 2023
Link:
https://hdl.handle.net/1..
?
5
Role of Notch2 pathway in mature B cell malignancies:
Mesini N
;
Fiorcari S
;
Atene C. G
...
info:eu-repo/semantics/altIdentifier/pmid/36686759. , 2023
Link:
https://hdl.handle.net/1..
?
6
Early palliative care versus usual haematological care in m..:
Giusti D
;
Colaci E
;
Pioli V
...
info:eu-repo/semantics/altIdentifier/pmid/37751995. , 2023
Link:
https://hdl.handle.net/1..
?
7
Reply to 'A case of dystrophic epidermolysis bullosa prurig..:
Martora, F.
;
Fabbrocini, G.
;
Nappa, P.
...
Journal of the European Academy of Dermatology and Venereology. 36 (2022) 9 - p. , 2022
Link:
https://doi.org/10.1111/..
?
8
Reply to 'Cutaneous adverse effects of the available COVID‐..:
Potestio, L.
;
Genco, L.
;
Villani, A.
...
Journal of the European Academy of Dermatology and Venereology. 36 (2022) 11 - p. , 2022
Link:
https://doi.org/10.1111/..
?
9
Genetic and Phenotypic Attributes of Splenic Marginal Zone ..:
Bonfiglio, Ferdinando
;
Bruscaggin, Alessio
;
Guidetti, Francesca
...
info:eu-repo/semantics/altIdentifier/pmid/34653238. , 2022
Link:
http://hdl.handle.net/24..
?
10
Efficacy of Front-Line Ibrutinib and Rituximab Combination ..:
Mauro F. R
;
Paoloni F
;
Molica S
...
info:eu-repo/semantics/altIdentifier/pmid/35008372. , 2022
Link:
https://hdl.handle.net/1..
?
11
The Role of T Cell Immunity in Monoclonal Gammopathy and Mu..:
Lagreca I
;
Riva G
;
Nasillo V
...
info:eu-repo/semantics/altIdentifier/pmid/35563634. , 2022
Link:
http://hdl.handle.net/11..
?
12
BTK Inhibitors Impair Platelet-Mediated Antifungal Activity:
Nasillo V
;
Lagreca I
;
Vallerini D
...
info:eu-repo/semantics/altIdentifier/pmid/35326454. , 2022
Link:
http://hdl.handle.net/11..
?
13
Genetic and phenotypic attributes of splenic marginal zone ..:
Bonfiglio F
;
Bruscaggin A
;
Guidetti F
...
info:eu-repo/semantics/altIdentifier/pmid/34653238. , 2022
Link:
http://hdl.handle.net/11..
?
14
Notch2 Increases the Resistance to Venetoclax-Induced Apopt..:
Fiorcari S
;
Maffei R
;
Atene C. G
...
info:eu-repo/semantics/altIdentifier/pmid/35070982. , 2022
Link:
http://hdl.handle.net/11..
?
15
Efficacy of Front-Line Ibrutinib and Rituximab Combination ..:
Mauro F. R
;
Paoloni F
;
Molica S
...
info:eu-repo/semantics/altIdentifier/wos/WOS:000771433100001. , 2022
Link:
http://hdl.handle.net/11..
1-15